Analyze Diet
Viruses2019; 11(10); doi: 10.3390/v11100963

Equine Rhinitis A Virus Infection in Thoroughbred Racehorses-A Putative Role in Poor Performance?

Abstract: The aim of this study was to identify respiratory viruses circulating amongst elite racehorses in a training yard by serological testing of serial samples and to determine their impact on health status and ability to race. A six-month longitudinal study was conducted in 30 Thoroughbred racehorses (21 two-year-olds, five three-year-olds and four four-year-olds) during the Flat racing season. Sera were tested for the presence of antibodies against equine herpesvirus 1 and 4 (EHV-1 and EHV-4) and equine rhinitis viruses A and B (ERAV and ERBV) by complement fixation (CF) and equine arteritis virus (EAV) by ELISA. Antibodies against equine influenza (EI) were measured by haemagglutination inhibition (HI). Only ERAV was circulating in the yard throughout the six-month study period. Seroconversion to ERAV frequently correlated with clinical respiratory disease and was significantly associated with subsequent failure to race (p = 0.0009). Over 55% of the two-year-olds in the study seroconverted to ERAV in May and June. In contrast, only one seroconversion to ERAV was observed in the older horses. They remained free of any signs of respiratory disease and raced successfully throughout the study period. The importance of ERAV as a contributory factor in the interruption of training programmes for young horses may be underestimated.
Publication Date: 2019-10-18 PubMed ID: 31635401PubMed Central: PMC6848918DOI: 10.3390/v11100963Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article
  • Research Support
  • Non-U.S. Gov't

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This study investigates respiratory viruses in elite racehorses, specifically equine rhinitis A Virus (ERAV), and their potential impact on the horses’ health and racing performance. Over a period of six months, one virus, ERAV, was found to be prevalent and its presence closely tied to respiratory disease and a subsequent decline in racing performance.

Objectives and Methodology of the Study

In the research:

  • The main goal was to identify and understand the impact of respiratory viruses on the health and performance of Thoroughbred racehorses.
  • The researchers specially investigated a range of potential viruses including equine herpesvirus 1 and 4 (EHV-1 and EHV-4), equine rhinitis viruses A and B (ERAV and ERBV), and equine arteritis virus (EAV).
  • The study involved a longitudinal examination of 30 Thoroughbred racehorses over six months during the Flat racing season.
  • Different testing methods such as complement fixation (CF) for EHV-1, EHV-4, ERAV and ERBV, and ELISA for EAV were employed. Haemagglutination inhibition (HI) was used to measure antibodies against equine influenza (EI).

Key Findings

The researchers made several important discoveries:

  • ERAV was the only virus found to be circulating in the racehorse yard consistently throughout the study period.
  • A significant correlation was found between the presence of ERAV and clinical respiratory disease in horses.
  • Furthermore, there was a strong association between seroconversion to ERAV and the horse’s failure to race, suggesting a potentially negative impact of ERAV infection on the horse’s racing performance.
  • A considerable percentage, over 55% of the two-year-olds involved in the study, showed seroconversion to ERAV, especially in the months of May and June.
  • In contrast, only a single seroconversion to ERAV was observed among older horses. Moreover, these older horses did not exhibit signs of respiratory disease and continued to perform well in races throughout the study period.

Conclusion of the Study

Based on the data gathered:

  • The study concluded that ERAV might play a crucial role in disrupting the training of young horses, a factor that possibly has been underestimated till now.
  • The study hypothesizes that the impact of ERAV on the racing capability of Thoroughbred racehorses, particularly young ones, warrants further research and attention in equine health management.

Cite This Article

APA
Back H, Weld J, Walsh C, Cullinane A. (2019). Equine Rhinitis A Virus Infection in Thoroughbred Racehorses-A Putative Role in Poor Performance? Viruses, 11(10). https://doi.org/10.3390/v11100963

Publication

ISSN: 1999-4915
NlmUniqueID: 101509722
Country: Switzerland
Language: English
Volume: 11
Issue: 10

Researcher Affiliations

Back, Helena
  • Department of Virology, Immunology and Parasitology, National Veterinary Institute, SE-751-89 Uppsala, Sweden. Helena.Back@mpa.se.
Weld, John
  • Riverdown, Barrettstown, Newbridge, Co. Kildare W12HD83, Ireland. johnweld1@eircom.net.
Walsh, Cathal
  • Department of Mathematics and Statistics, University of Limerick, Castletroy, Limerick V94 T9PX, Ireland. Cathal.Walsh@ul.ie.
Cullinane, Ann
  • Virology Unit, The Irish Equine Centre, Johnstown, Naas, Co. KildareW91RH93, Ireland. ACullinane@irishequinecentre.ie.

MeSH Terms

  • Animals
  • Antibodies, Viral / blood
  • Aphthovirus / immunology
  • Breeding
  • Horse Diseases / virology
  • Horses / virology
  • Longitudinal Studies
  • Male
  • Picornaviridae Infections / veterinary
  • Respiratory Tract Infections / veterinary
  • Respiratory Tract Infections / virology
  • Running
  • Sports

Conflict of Interest Statement

The authors declare no conflict of interest.

References

This article includes 34 references
  1. Wilsher S, Allen WR, Wood JL. Factors associated with failure of thoroughbred horses to train and race.. Equine Vet. J. 2006;38:113–118.
    doi: 10.2746/042516406776563305pubmed: 16536379google scholar: lookup
  2. Cullinane A, Newton JR. Equine influenza-A global perspective.. Vet. Microbiol. 2013;167:205–214.
    doi: 10.1016/j.vetmic.2013.03.029pubmed: 23680107google scholar: lookup
  3. Newton JR, Daly JM, Spencer L, Mumford JA. Description of the outbreak of equine influenza (H3N8) in the United Kingdom in 2003, during which recently vaccinated horses in Newmarket developed respiratory disease.. Vet. Rec. 2006;158:185–192.
    doi: 10.1136/vr.158.6.185pubmed: 16474051google scholar: lookup
  4. Gildea S, Arkins S, Cullinane A. Management and environmental factors involved in equine influenza outbreaks in Ireland 2007-2010.. Equine Vet. J. 2011;43:608–617.
  5. Gildea S, Fitzpatrick DA, Cullinane A. Epidemiological and virological investigations of equine influenza outbreaks in Ireland (2010-2012). Influenza Other Respir. Viruses 2013;7(Suppl. 4):61–72.
    doi: 10.1111/irv.12192pmc: PMC5655889pubmed: 24224821google scholar: lookup
  6. Willoughby R, Ecker G, McKee S, Riddolls L, Vernaillen C, Dubovi E, Lein D, Mahony JB, Chernesky M, Nagy E. The effects of equine rhinovirus, influenza virus and herpesvirus infection on tracheal clearance rate in horses.. Can. J. Vet. Res. 1992;56:115–121.
    pmc: PMC1263518pubmed: 1317244
  7. Allen GP, Kydd J, Slater JD, Smith KC. Equid herpesvirus 1 and equid herpesvirus 4 infections.. In: Coetzer J.A.W., Tustin R.C., editors. Infectious Diseases on Livestock. 2nd ed. Oxford Press; Cape Town, South Africa: 2004. pp. 829–859.
  8. Pusterla N, Kass PH, Mapes S, Johnson C, Barnett DC, Vaala W, Gutierrez C, McDaniel R, Whitehead B, Manning J. Surveillance programme for important equine infectious respiratory pathogens in the USA.. Vet. Rec. 2011;169:12.
    doi: 10.1136/vr.d2157pubmed: 21676986google scholar: lookup
  9. Burgess BA, Tokateloff N, Manning S, Lohmann K, Lunn DP, Hussey SB, Morley PS. Nasal shedding of equine herpesvirus-1 from horses in an outbreak of equine herpes myeloencephalopathy in Western Canada.. J. Vet. Intern. Med. 2012;26:384–392.
  10. Carman S, Rosendal S, Huber L, Gyles C, McKee S, Willoughby RA, Dubovi E, Thorsen J, Lein D. Infectious agents in acute respiratory disease in horses in Ontario.. J. Vet. Diagn. Invest. 1997;9:17–23.
    doi: 10.1177/104063879700900104pubmed: 9087920google scholar: lookup
  11. Li F, Drummer HE, Ficorilli N, Studdert MJ, Crabb BS. Identification of noncytopathic equine rhinovirus 1 as a cause of acute febrile respiratory disease in horses.. J. Clin. Microbiol. 1997;35:937–943.
    pmc: PMC229704pubmed: 9157156
  12. Plummer G. An equine respiratory virus with enterovirus properties.. Nature 1962;195:519–520.
    doi: 10.1038/195519a0pubmed: 14487261google scholar: lookup
  13. Studdert M, Gleeson L. Isolation and characterisation of an equine rhinovirus.. Zentralbl Veterinarmed B 1978;25:225–237.
  14. Diaz-Mendez A, Viel L, Hewson J, Doig P, Carman S, Chambers T, Tiwari A, Dewey C. Surveillance of equine respiratory viruses in Ontario.. Can. J. Vet. Res. 2010;74:271–278.
    pmc: PMC2949340pubmed: 21197227
  15. Ditchfield J, Macpherson L. Properties and classification of 2 new rhinoviruses recovered from horses in Toronto.. Cornell. Vet. 1965;55:181–189.
    pubmed: 14317475
  16. Sugiura T, Matsumura T, Imagawa H, Fukunaga Y. A seven year serological study of viral agents causing respiratory infection with pyrexia among racehorses in Japan.. In: Powell DG, editor. Equine Infectious Diseases V. University of Kentucky Publications; Lexington, NY, USA: 1988. pp. 258–261.
  17. McCollum W, Timoney P. Studies on the seroprevalence and frequency of equine rhinovirus-I and-II infection in normal horse urine.. In: Plowright W, Rossdale PD, Wade JF, editors. Equine Infectious Diseases VI. R&W Publications; Newmarket, UK: 1992. pp. 83–87.
  18. Black WD, Wilcox RS, Stevenson RA, Hartley CA, Ficorilli NP, Gilkerson JR, Studdert MJ. Prevalence of serum neutralising antibody to equine rhinitis A virus (ERAV), equine rhinitis B virus 1 (ERBV1) and ERBV2.. Vet. Microbiol. 2007;119:65–71.
    doi: 10.1016/j.vetmic.2006.08.031pubmed: 17046179google scholar: lookup
  19. Klaey M, Sanchez-Higgins M, Leadon DP, Cullinane A, Straub R, Gerber H. Field case study of equine rhinovirus 1 infection: clinical signs and clinicopathology.. Equine Vet. J. 1998;30:267–269.
  20. Powell DG, Burrows R, Spooner P, Mumford J, Thomson G. A study of infectious respiratory disease among horses in Great Britain, 1971-1976.. In: Bryans JT, Gerber H, editors. Equine Infectious Diseases IV. Veterinary Publications; Princeton, NJ, USA: 1978. pp. 451–459.
  21. Burrell MH, Wood JL, Whitwell KE, Chanter N, Mackintosh ME, Mumford JA. Respiratory disease in thoroughbred horses in training: the relationships between disease and viruses, bacteria and environment.. Vet. Rec. 1996;139:308–313.
    doi: 10.1136/vr.139.13.308pubmed: 8893488google scholar: lookup
  22. Cardwell J, Smith K, Wood J, Newton J. A longitudinal study of respiratory infections in British National Hunt racehorses.. Vet. Rec. 2013;172:637.
    doi: 10.1136/vr.101520pubmed: 23650184google scholar: lookup
  23. Wood JL, Newton JR, Chanter N, Mumford JA. Association between respiratory disease and bacterial and viral infections in British racehorses.. J. Clin. Microbiol. 2005;43:120–126.
  24. Thomson GR, Mumford JA, Campbell J, Griffiths L, Clapham P. Serological detection of equid herpesvirus 1 infections of the respiratory tract.. Equine Vet. J. 1976;8:58–65.
  25. Cullinane A, Weld J, Osborne M, Nelly M, McBride C, Walsh C. Field studies on equine influenza vaccination regimes in thoroughbred foals and yearlings.. Vet. J. 2001;161:174–185.
    doi: 10.1053/tvjl.2000.0546pubmed: 11243687google scholar: lookup
  26. Hofer B, Steck F, Gerber H, Löhrer J, Nicolet J, Paccaud M. An Investigation of the Etiology of Viral Respiratory Disease in a Remount Depot.. In: Bryans JT, Gerber H, editors. Equine Infectious Diseases III. Karger; Basel, Switzerland: 1973. pp. 527–545.
  27. Burrows R. Equine rhinovirus and adenovirus infections; Proceedings of the 24th Annual Convention of the American Association of Equine Practitioners; St. Louis, MO, USA.. 1978; pp. 299–306.
  28. Plummer G. Studies on an equine respiratory virus.. Vet. Rec. 1962;74:967–970.
  29. Diaz-Mendez A, Hewson J, Shewen P, Nagy E, Viel L. Characteristics of respiratory tract disease in horses inoculated with equine rhinitis A virus.. Am. J. Vet. Res. 2014;75:169–178.
    doi: 10.2460/ajvr.75.2.169pubmed: 24471753google scholar: lookup
  30. Quinlivan M, Maxwell G, Lyons P, Arkins S, Cullinane A. Real-time RT-PCR for the detection and quantitative analysis of equine rhinitis viruses.. Equine Vet. J. 2010;42:98–104.
    doi: 10.2746/042516409X479559pubmed: 20156243google scholar: lookup
  31. Lynch SE, Gilkerson JR, Symes SJ, Huang JA, Hartley CA. Persistence and chronic urinary shedding of the aphthovirus equine rhinitis A virus.. Comp. Immunol. Microbiol. Infect. Dis. 2013;36:95–103.
    doi: 10.1016/j.cimid.2012.10.003pubmed: 23183058google scholar: lookup
  32. De Boer GF, Osterhaus AD, van Oirschot JT, Wemmenhove R. Prevalence of antibodies to equine viruses in the Netherlands.. Tijdschr. Diergeneeskd. 1979;104:65–74.
    doi: 10.1080/01652176.1979.9693724pubmed: 219560google scholar: lookup
  33. Burrows R, Goodridge D. Observations of picornavirus, adenovirus, and equine herpesvirus infections in the Pirbright pony herd.. In: Bryans JT, Gerber H, editors. Equine Infectious Diseases IV. Veterinary Publications; Princeton, NJ, USA: 1978. pp. 155–164.
  34. Burrows R. Equine rhinoviruses.. In: Bryans JT, Gerber H, editors. Proceedings of the Equine Infectious Diseases II; Paris, France. 16–18 June 1969; Basel, Switzerland: Karger; 1970. pp. 154–164.

Citations

This article has been cited 5 times.